![Core Concepts - Opportunistic Infections: Prevention - Co-Occurring Conditions - National HIV Curriculum Core Concepts - Opportunistic Infections: Prevention - Co-Occurring Conditions - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/885-2/aids-defining-opportunistic-illnesses-united-states-canadana-accord-20002010.jpg)
Core Concepts - Opportunistic Infections: Prevention - Co-Occurring Conditions - National HIV Curriculum
![Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis](https://static.hindawi.com/articles/criid/volume-2020/8532780/figures/8532780.fig.001.jpg)
Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis
![Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation | European Respiratory Society Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation | European Respiratory Society](https://erj.ersjournals.com/content/erj/35/4/927/F1.large.jpg)
Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation | European Respiratory Society
![Pneumocystis carinii Pneumonia in Infants Infected with the Human Immunodeficiency Virus with More Than 450 CD4 T Lymphocytes per Cubic Millimeter | NEJM Pneumocystis carinii Pneumonia in Infants Infected with the Human Immunodeficiency Virus with More Than 450 CD4 T Lymphocytes per Cubic Millimeter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1990/nejm_1990.323.issue-8/nejm199008233230807/production/images/img_medium/nejm199008233230807_t1.jpeg)
Pneumocystis carinii Pneumonia in Infants Infected with the Human Immunodeficiency Virus with More Than 450 CD4 T Lymphocytes per Cubic Millimeter | NEJM
![Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis](https://static.hindawi.com/articles/criid/volume-2020/8532780/figures/8532780.fig.004.jpg)
Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis
![Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients | Scientific Reports Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-26743-4/MediaObjects/41598_2018_26743_Fig1_HTML.jpg)
Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients | Scientific Reports
![Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature. - Abstract - Europe PMC Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4553998/bin/medi-94-e681-g001.jpg)
Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature. - Abstract - Europe PMC
![Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-018-2221-8/MediaObjects/13054_2018_2221_Fig1_HTML.png)
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text
Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review | PLOS ONE
![Frontiers | Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review Frontiers | Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review](https://www.frontiersin.org/files/Articles/276699/fped-05-00161-HTML/image_m/fped-05-00161-g001.jpg)
Frontiers | Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review
![Pneumocystis jiroveci Pneumonia (PJP): Overview of Pneumocystis jiroveci Pneumonia, Microbiology of Pneumocystis jiroveci Pneumonia, Pathophysiology and Etiology of Pneumocystis jiroveci Pneumonia Pneumocystis jiroveci Pneumonia (PJP): Overview of Pneumocystis jiroveci Pneumonia, Microbiology of Pneumocystis jiroveci Pneumonia, Pathophysiology and Etiology of Pneumocystis jiroveci Pneumonia](https://img.medscapestatic.com/pi/meds/ckb/46/14246tn.jpg)
Pneumocystis jiroveci Pneumonia (PJP): Overview of Pneumocystis jiroveci Pneumonia, Microbiology of Pneumocystis jiroveci Pneumonia, Pathophysiology and Etiology of Pneumocystis jiroveci Pneumonia
![Prophylaxis against Pneumocystis carinii Pneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States | NEJM Prophylaxis against Pneumocystis carinii Pneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1995/nejm_1995.332.issue-12/nejm199503233321206/production/images/img_medium/nejm199503233321206_f1.jpeg)
Prophylaxis against Pneumocystis carinii Pneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States | NEJM
![Core Concepts - Opportunistic Infections: Prevention - Co-Occurring Conditions - National HIV Curriculum Core Concepts - Opportunistic Infections: Prevention - Co-Occurring Conditions - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/668-3/aids-defining-opportunistic-illnesses-united-stateshiv-outpatient-cohort-study-19942007.jpg)